Cargando…

Sevelamer carbonate experience in Indian end stage renal disease patients

This open label, multicentric, comparative clinical trial was done to compare the efficacy and tolerability of two sevelamer formulations, sevelamer carbonate, and sevelamer hydrochloride, in the treatment of hyperphosphatemia in Indian end stage renal disease (ESRD) patients. A total of 97 ESRD pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abraham, G., Kher, V., Saxena, S., Jayakumar, M., Chafekar, D., Pargaonkar, P., Shetty, M., Reddy, Y. N. V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459522/ https://www.ncbi.nlm.nih.gov/pubmed/23087553 http://dx.doi.org/10.4103/0971-4065.98754

Ejemplares similares

Development and Validation of a Gas Chromatography Method for the Trace Level Determination of Allylamine in Sevelamer Hydrochloride and Sevelamer Carbonate Drug Substances
por: Kadiyala, Raju V. S. N., et al.
Publicado: (2014)

Sevelamer carbonate reduces the risk of hypomagnesemia in hemodialysis-requiring end-stage renal disease patients
por: Rosa-Diez, Guillermo, et al.
Publicado: (2016)

Sevelamer-Associated Rectosigmoid Ulcers in an End-Stage Renal Disease Patient
por: Uy, Pearl Princess, et al.
Publicado: (2018)

Clinical and economic aspects of sevelamer therapy in end-stage renal disease patients
por: Ossareh, Shahrzad
Publicado: (2014)

Optimal management of hyperphosphatemia in end-stage renal disease: an Indian perspective
por: Reddy, Yogesh NV, et al.
Publicado: (2014)

Sevelamer Carbonate Crystal-Induced Colitis
por: Lai, T., et al.
Publicado: (2020)

A meta-analysis of phosphate binders lanthanum carbonate versus sevelamer hydrochloride in patients with end-stage renal disease undergoing hemodialysis
por: Zhou, Tianbiao, et al.
Publicado: (2018)

Ischemic Colitis in Association with Sevelamer Crystals
por: Keri, K. C., et al.
Publicado: (2019)

Effect of Sevelamer and Nicotinamide on Albumin Carbamylation in Patients with End-Stage Kidney Disease
por: Lenglet, Aurelie, et al.
Publicado: (2021)

Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease
por: Rastogi, Anjay
Publicado: (2013)

Colonic Mucosal Ulceration and Gastrointestinal Bleeding Associated with Sevelamer Crystal Deposition in a Patient with End Stage Renal Disease
por: Nambiar, Sudheer, et al.
Publicado: (2018)

The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol
por: Pierce, David, et al.
Publicado: (2011)

Sevelamer reduces endothelial inflammatory response to advanced glycation end products
por: Gregório, Paulo C, et al.
Publicado: (2018)

A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis
por: Fan, Stanley, et al.
Publicado: (2009)

Comparison of Sevelamer and Calcium Carbonate in Prevention of Hypomagnesemia in Hemodialysis Patients
por: Jandaghi, Elahe, et al.
Publicado: (2021)

Sevelamer carbonate increases serum bicarbonate in pediatric dialysis patients
por: Gonzalez, Elsa, et al.
Publicado: (2010)

Update and critical appraisal of sevelamer in the management of chronic renal failure
por: Grinfeld, Jacob, et al.
Publicado: (2010)

Evaluating the effects of sevelamer carbonate on cardiovascular structure and function in chronic renal impairment in Birmingham: the CRIB-PHOS randomised controlled trial
por: Chue, Colin D, et al.
Publicado: (2011)

Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis
por: Savica, Vincenzo, et al.
Publicado: (2008)

Fetuin-A and vascular calcification in Indian end-stage renal disease population
por: Mann, A., et al.
Publicado: (2016)

Late post transplant HIV infection with BK viremia and allograft tuberculosis in a renal transplant recipient with Kaposi sarcoma
por: Viswanathan, V., et al.
Publicado: (2012)

Correction of metabolic acidosis after conversion from sevelamer hydrochloride to lanthanum carbonate
por: Lindley, Elizabeth, et al.
Publicado: (2008)

Gastrointestinal complications induced by sevelamer crystals
por: Yuste, Claudia, et al.
Publicado: (2017)

Incremental cost-utility of sevelamer relative to calcium carbonate for treatment of hyperphosphatemia among pre-dialysis chronic kidney disease patients
por: Nguyen, Hai V., et al.
Publicado: (2016)

Carotid intima-media thickness in patients with end-stage renal disease
por: Sunil Kumar, K., et al.
Publicado: (2009)

Sevelamer-Induced Gastrointestinal Injury Presenting as Gastroenteritis
por: Magee, Jared, et al.
Publicado: (2018)

Sevelamer Attenuates Bioprosthetic Heart Valve Calcification
por: Meng, Zhen, et al.
Publicado: (2021)

Binding interactions with sevelamer and polystyrene sulfonate in vitro
por: van Berlo‐van de Laar, Inge R.F., et al.
Publicado: (2021)

Phosphate Binding with Sevelamer Preserves Mechanical Competence of Bone Despite Acidosis in Advanced Experimental Renal Insufficiency
por: Jokihaara, Jarkko, et al.
Publicado: (2016)

Efficacy of Lanthanum Carbonate and Sevelamer Carbonate as Phosphate Binders in Chronic Kidney Disease—A Comparative Clinical Study
por: Nain, Parminder, et al.
Publicado: (2023)

Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3
por: Bouma-de Krijger, Annet, et al.
Publicado: (2019)

Endotoxin Binding by Sevelamer: Potential Impact on Nutritional Status
por: Kubotera, Natsuki, et al.
Publicado: (2013)

Colonic Mass Secondary to Sevelamer-Associated Mucosal Injury
por: Bansal, Vishant, et al.
Publicado: (2017)

Sevelamer crystals—an unusual cause of large bowel obstruction
por: Cockrell, Hannah C, et al.
Publicado: (2021)

A case report of sevelamer-associated recto-sigmoid ulcers
por: Tieu, Christina, et al.
Publicado: (2016)

Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease–mineral bone disorder parameters in dialysis patients
por: Ketteler, Markus, et al.
Publicado: (2019)

Effect of Sevelamer on Calciprotein Particles in Hemodialysis Patients: The Sevelamer Versus Calcium to Reduce Fetuin-A-Containing Calciprotein Particles in Dialysis (SCaRF) Randomized Controlled Trial
por: Smith, Edward R., et al.
Publicado: (2020)

Different Effect of Lanthanum Carbonate and Sevelamer Hydrochloride on Calcium Balance in Patients with Moderate to Advanced Chronic Kidney Disease
por: Makowka, Agnieszka, et al.
Publicado: (2021)

Effects of sevelamer carbonate versus calcium acetate on vascular calcification, inflammation, and endothelial dysfunction in chronic kidney disease
por: Mason, Darius L., et al.
Publicado: (2021)

The Influence of Sevelamer Hydrochloride and Calcium Carbonate on Markers of Inflammation and Oxidative Stress in Hemodialysis at Six Months of Follow-Up
por: Díaz-De la Cruz, Elodia Nataly, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_98iu5bbeon1nien2hjsrve6nab